Substantial gains in market share for GLP-1 receptor agonists and SGLT-2 inhibitors, notes GlobalData

Data and analytics company, GlobalData, has observed substantial gains in market share across the seven major markets (7MM) of glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter-2 (SGLT-2) inhibitors. Read more

13 Mar 2018 13:51 Analysis